DrugPatentWatch Database Preview
MORPHABOND ER Drug Profile
Email this page to a colleague
» See Plans and PricingWhen do Morphabond Er patents expire, and what generic alternatives are available?
Morphabond Er is a drug marketed by Daiichi Sankyo Inc and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.
This drug has twenty-three patent family members in ten countries.
The generic ingredient in MORPHABOND ER is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
US ANDA Litigation and Generic Entry Outlook for Morphabond Er
A generic version of MORPHABOND ER was approved as morphine sulfate by HOSPIRA on May 11th, 1988.
Summary for MORPHABOND ER
| International Patents: | 23 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 19 |
| Patent Applications: | 3,000 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for MORPHABOND ER |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for MORPHABOND ER |
| DailyMed Link: | MORPHABOND ER at DailyMed |
Pharmacology for MORPHABOND ER
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
Paragraph IV (Patent) Challenges for MORPHABOND ER
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| MORPHABOND ER | TABLET, EXTENDED RELEASE;ORAL | morphine sulfate | 206544 | 2019-01-28 |
US Patents and Regulatory Information for MORPHABOND ER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Daiichi Sankyo Inc | MORPHABOND ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 206544-001 | Oct 2, 2015 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Daiichi Sankyo Inc | MORPHABOND ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 206544-004 | Oct 2, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Daiichi Sankyo Inc | MORPHABOND ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 206544-002 | Oct 2, 2015 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for MORPHABOND ER
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2017200414 | Start Trial |
| Japan | 2016138126 | Start Trial |
| Mexico | 336789 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
